Skip to main content
Clinical Trials/NL-OMON55513
NL-OMON55513
Completed
Not Applicable

Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies - ASE Study protocol C2081

Boston Scientific0 sites42 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cardiovascular disease
Sponsor
Boston Scientific
Enrollment
42
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Subject is scheduled to receive a de novo S\-ICD system implant per labeled
  • 2\. Passing S\-ICD screening ECG performed per applicable user's manual.
  • 3\. Subject is expected to be implanted with a left parasternal S\-ICD electrode.
  • 4\. Subject\*s planned S\-ICD implant procedure will include at least one VF
  • conversion testing at 65 J.
  • 5\. Subject is willing and capable of providing informed consent specific to
  • local and national laws.
  • 6\. Subject is age 18 or above, or of legal age to give informed consent
  • specific to local and national law.

Exclusion Criteria

  • 1\. Subject has an unusual chest anatomy (eg. pectus excavatum and pectus
  • carinatum) that might impede the ability to temporarily insert a second S\-ICD
  • 2\. Subject has a left ventricular ejection fraction less than or equal to 20%
  • within 3 months prior to enrollment.
  • 3\. Subject has NYHA Class IV or unstable Class III heart failure.
  • 4\. Subject that, in the opinion of the investigator, cannot tolerate the DFT
  • testing required by this protocol.
  • 5\. Subject that, in the opinion of the investigator, is at increased risk for
  • VF conversion failure.
  • 6\. Subject is morbidly obese, defined as BMI greater than or equal to 35\.

Outcomes

Primary Outcomes

Not specified

Similar Trials